Cheers @Phaedrus for the information. I will do some further reading.
As a SH, I’m thrilled Mesoblast is ethical & compassionate. I would not want this to change (nor do I expect it to).
I would be a little peeved with the FDA if since the CR letter, MSB has treated patients suffering SR-agvhd. Again, I don’t begrudge any patients or MSB BUT I would not be happy with FDA if they are taking advantage of MSB shareholders.
MSB Trading 2021 - paradigm shift, page-3884
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.103(9.45%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $8.016M | 6.867M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9050 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 54256 | 8 |
View Market Depth
| Last trade - 11.08am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
0.103 ( 7.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 1764273 | ||
| Last updated 11.27am 06/05/2024 ? | |||||
| MSB (ASX) Chart |